TrialBMC cancer2009

In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer.

Anne E Lykkesfeldt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.